Acquisition of Respiratory System Medications

This tender concerns the acquisition of medications specifically for the respiratory system. This includes pharmaceuticals used to treat a range of respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), infections, and other lung-related ailments. The procurement aims to ensure the availability of essential medicines for patients suffering from respiratory diseases. The scope likely involves sourcing various types of respiratory drugs, which could include inhalers, nebulizer solutions, antibiotics, corticosteroids, and expectorants. The procuring entity, likely a healthcare provider or public health organization, is seeking to secure a reliable supply of these critical medications. Bidders are expected to be pharmaceutical manufacturers or distributors capable of supplying these drugs in compliance with quality standards and regulatory requirements. The tender will specify the exact list of medications, quantities, and delivery conditions. This acquisition is crucial for providing effective treatment and managing respiratory health conditions within the population served.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 294.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.